# Gastrointestinal Stromal Tumor Market Global Leading Companies Analysis, Revenue, Trends and Forecasts 2027
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-25
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Gastrointestinal Stromal Tumor Market: AI and Digital
Meta Description: Explore new technologies and treatments shaping the $1.5 Billion market with AI-enabled devices and telemedicine for the upcoming period.
URL: https://financedigest.com/gastrointestinal-stromal-tumor-market-global-leading-companies-analysis-revenue-trends-and-forecasts-2027html

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836937157-compressed.jpg)

The Gastrointestinal Stromal Tumor Market is all set to be in the driver’s seat shortly. Technology adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the form of granular applications. Technologies like DevOps and AIOps are constructively disrupting the healthcare IT sector and are [expected to create wonders in this regard in the upcoming period](https://www.financedigest.com/wind-turbine-generator-market-is-expected-to-reach-net-valuation-of-more-than-us-90-7bn-during-forecast-period-of-2021-to-2031.html "Wind Turbine Generator Market Is Expected To Reach Net Valuation Of More Than US$ 90.7Bn During Forecast Period Of 2021 To 2031").

The [**Gastrointestinal Stromal Tumor Market**](https://www.persistencemarketresearch.com/market-research/gastrointestinal-stromal-tumor-market.asp) is expected to be worth US$ 1.5 Billion at a CAGR of 6.6% between 2026. Healthcare is going the “digital” way. In other words, [artificial intelligence](https://www.financedigest.com/types-of-artificial-intelligence.html "artificial intelligence") (AI)-enabled medical devices and telemedicine are the concrete instances of the proliferation of the digital wave in the healthcare industry. This [factor would be the one traversing the healthcare vertical in the forecast](https://www.financedigest.com/milking-salve-market-in-depth-overview-growth-factors-regional-analysis-and-forecasts-outlook-2030.html "Milking Salve Market In-Depth Overview, Growth Factors, Regional Analysis and Forecasts Outlook-2030") period.

Persistence Market Research’s exclusive forecast study on the [global](https://www.financedigest.com/global-bank-bonds-claw-back-losses-as-markets-rout-eases.html "Global bank bonds claw back losses as markets rout eases") market for gastrointestinal stromal tumor (GIST) estimates that the treatments for such malignant cancer will bring in more than **US$ 1.5 Bn** revenues, globally, by the end of 2026.

The study has addressed a range of factors influencing the growth of the [global gastrointestinal stromal tumor market for](https://www.financedigest.com/global-2023-economic-view-downgraded-at-odds-with-market-optimism-reuters-poll.html "Global 2023 economic view downgraded, at odds with market optimism: Reuters poll") the assessment period, 2017-2026. From genetic changes to bad dietary lifestyles and increasing presence of adulterants in common foods, several factors are expected to [fuel the demand](https://www.financedigest.com/oil-falls-on-concerns-economic-slowdown-may-dent-fuel-demand.html "Oil falls on concerns economic slowdown may dent fuel demand") for treatments on GISTs.

**How About Looking Through The Sample Of Gastrointestinal Stromal Tumor Market Report?** **https://www.persistencemarketresearch.co/samples/20626**

[**Company Profiles**](https://www.financedigest.com/air-classifiers-market-trend-forecast-drivers-restraints-company-profiles-and-key-players-analysis-by-2029.html "Air Classifiers Market Trend, Forecast, Drivers, Restraints, Company Profiles And Key Players Analysis By 2029")

- Novartis AG
- Sun Pharmaceutical Industries Limited
- Pfizer Inc.
- Bayer Aktiengesellschaft
- NATCO Pharma Limited

**Get A Customized Scope To Match Your Need Ask An Expert –** [**sales@persistencemarketresearch.com**](mailto:sales@persistencemarketresearch.com)

While most of the drivers for the [global gastrointestinal stromal tumor market are indicative of driving](https://www.financedigest.com/india-resists-calls-for-more-air-access-in-drive-to-be-global-aviation-force.html "India resists calls for more air access in drive to be global aviation force") the incidence of this tumor, some factors are expected to represent patient attitudes and pharmaceutical outcomes.

During the forecast period, the [global gastrointestinal stromal tumor market](https://www.financedigest.com/how-2022-shocked-rocked-and-rolled-global-markets.html "How 2022 shocked, rocked and rolled global markets") is estimated to expand robustly at a **CAGR of 6.6%**. Increasing developments in the research on new drug candidates for controlling the outgrowth of gastrointestinal stromal tumor cells will be factoring the [market’s growth](https://www.financedigest.com/lentils-flour-market-overview-cost-structure-analysis-growth-opportunities-and-forecast-to-2029.html "Lentils Flour Market Overview, Cost Structure Analysis, Growth Opportunities And Forecast To 2029") to a considerable extent. Notwithstanding as one of the most common forms of cancer, the incidence rate of GIST continues to be remarkably low.

The [World Health Organization](https://www.financedigest.com/corporate-events-in-the-post-corona-world-how-to-organize-them-at-best.html "Corporate events in the post-Corona world, how to organize them at best") states that in the US, the estimated incidence rate of gastrointestinal stromal tumor is 14.5 per million. The study projects that through 2026, North America will be observed as the largest market for gastrointestinal stromal tumor.

Increasing presence of genetic disorders in the US, robust healthcare infrastructure, availability of exclusive medical facilitates for caretaking of patients suffering from inoperable cancers will [continue to drive the growth](https://www.financedigest.com/multilocal-hires-new-directors-as-steep-growth-trajectory-continues.html "Multilocal hires new directors as steep growth trajectory continues") of North America’s gastrointestinal stromal tumor market through 2026.

Over the forecast period, the gastrointestinal stromal tumor market in North America is anticipated to register a [**6.9% CAGR** style=”font-weight: 400;”>, recording highest revenues. The study also estimates that Europe will be at the forefront of the](https://www.financedigest.com/the-automotive-parts-aftermarket-to-have-innovation-based-clout-in-its-armor-at-a-cagr-of-6-9-from-2021-to-2031.html "The Automotive Parts Aftermarket to have innovation-based clout in its armor at a CAGR of 6.9% from 2021 to 2031") [global gastrointestinal stromal tumor market](https://www.financedigest.com/the-feds-rate-hike-that-wasnt-and-brexit-a-snapshot-of-global-financial-markets.html "The Fed’s rate hike that wasn’t and Brexit: a snapshot of global financial markets") expansion during the forecast period.

**Want To Keep A Tab On The Latest Findings In The Gastrointestinal Stromal Tumor Market? Purchase Our Gastrointestinal Stromal Tumor Market Report Now!** [**https://www.persistencemarketresearch.com/checkout/20626**](https://www.persistencemarketresearch.com/checkout/20626)

**Patients to Opt for Conventional Symptomatic Treatments such as Chemotherapy**

Being inoperable in nature, gastrointestinal stromal tumor has a [limited treatment scope](https://www.financedigest.com/digital-euro-will-be-free-but-limited-in-scope-ecb-says.html "Digital euro will be free but limited in scope, ECB says"). The role of radiotherapy in gastrointestinal stromal tumor treatment remains unestablished till date. Patients seek symptomatic treatments such as chemotherapy while medical professionals await a clinical practice breakthrough.

In 2017, more than US$ 185 Mn worth of revenues were procured globally from treatment of gastrointestinal stromal tumor with chemotherapy. The study also projects that targeted drug therapy will [gain traction as a viable treatment for early-stage GISTs in the foreseeable future](https://www.financedigest.com/dollar-gains-as-wall-street-retreats-on-future-fed-hikes.html "Dollar gains as Wall Street retreats on future Fed hikes").

**Difficulties in Clearing FDA Pipeline**

Currently, the competition landscape in the [global gastrointestinal stromal tumor market](https://www.financedigest.com/theresa-may-brexit-and-risk-and-safe-assets-a-snapshot-of-global-financial-markets.html "Theresa May, Brexit and risk and safe assets: A snapshot of global financial markets") exhibits the presence of only a handful of players. Companies namely, Sun Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., NATCO Pharma Limited, and Bayer Aktiengesellschaft are expected to remain [active in expansion of the global](https://www.financedigest.com/global-factory-activity-weakens-as-demand-falters.html "Global factory activity weakens as demand falters") GIST market from 2017 to 2026.

Several leading pharma [companies are anticipated to penetrate the consolidated competition in the global market](https://www.financedigest.com/5-digital-marketing-tips-to-keep-insurance-companies-competitive.html "5 digital marketing tips to keep insurance companies competitive") during the forecast period. Unable to clear the FDA approvals remains the key impediment and entry barrier in the [global gastrointestinal stromal tumor market](https://www.financedigest.com/liverpool-property-market-embraces-new-global-appeal-as-international-music-festival-comes-to-town.html "Liverpool property market embraces new global appeal as International Music Festival comes to town ").

**High End-use in Hospitals; Stomach Indication to Account for Nearly 3/5** **th** **Share of Global Revenues**

Additional [research findings from the report reveal that stomach is the key segment](https://www.financedigest.com/elevators-and-escalators-market-research-report-overview-with-geographical-segmentation-by-revenue-with-forecast-2026.html "Elevators And Escalators Market Research Report: Overview With Geographical Segmentation By Revenue With Forecast 2026") in terms of indication of GISTs. While the occurrence of gastrointestinal stromal tumor may take place in any part of the GI tract, its localization remains common in the stomach.

In 2017, stomach as an indication will account for nearly **US$ 500 Mn** revenues in the [global market](https://www.financedigest.com/primayer-case-study-relieving-the-pressure-on-water-companies-and-opening-global-markets.html "Primayer case study: Relieving the pressure on water companies and opening global markets"). The [report also expects that hospitals will be the largest end-users in the global](https://www.financedigest.com/global-economy-weathered-98bn-natural-hazard-loss-in-first-half-of-2016-according-to-aon-catastrophe-report.html "GLOBAL ECONOMY WEATHERED BN NATURAL HAZARD LOSS IN FIRST HALF OF 2016, ACCORDING TO AON CATASTROPHE REPORT") market, and will rake in over **US$ 485 Mn** revenues from treatments of GISTs by 2026-end.

**About us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact us:**

**Persistence** [Market Research](https://www.financedigest.com/condensed-whey-market-research-report-2022-global-forecast-till-2028.html "Condensed Whey Market Research Report 2022 – Global Forecast till 2028")

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Sales** – sales@persistencemarketresearch.com


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---